Why Peptide Half-Life Matters in Research
When researchers design peptide studies, one of the most critical variables is half-life — the time it takes for a peptide's concentration in a biological system to decrease by 50%. Understanding half-life helps determine administration frequency, stability windows, and how long a compound remains active in a research model.
Without a reliable reference, comparing peptides across studies becomes inconsistent and difficult to replicate. This complete peptide half-life chart is designed to give researchers a clear, consolidated starting point.
What Affects a Peptide's Half-Life?
Several structural and environmental factors influence how long a peptide remains intact and active. Research suggests the following are among the most significant variables:
- Amino acid sequence and length: Shorter peptides are typically degraded faster by endogenous proteases.
- Modifications: PEGylation, acetylation, and DAC (Drug Affinity Complex) attachments can significantly extend half-life.
- Route of administration: Subcutaneous and intramuscular routes generally produce slower absorption and longer effective duration compared to intravenous delivery.
- Peptide bonds: D-amino acid substitutions resist enzymatic cleavage, extending stability in biological environments.
- Temperature and storage: Peptides degrade faster when improperly stored; lyophilized (freeze-dried) forms typically offer superior shelf stability.
Complete Peptide Half-Life Reference Chart
The following table summarizes commonly researched peptides, their approximate half-lives, and standard administration routes observed in published animal and in-vitro studies. These figures represent research-model data and should not be interpreted as human clinical guidelines.
Healing and Recovery Peptides
- BPC-157: Approximately 4 hours (subcutaneous); stable gastric form may persist longer in GI research models. Studies indicate strong tissue-protective properties in rodent models. Bpc 157
- TB-500 (Thymosin Beta-4): Estimated half-life of 2–3 days due to its larger molecular structure; research suggests it may support actin regulation and cellular migration in studied tissue models.
- GHK-Cu (Copper Tripeptide): Short half-life of approximately 30–60 minutes in plasma; however, copper-binding properties may extend localized activity at the tissue level.
Growth Hormone Secretagogues
- CJC-1295 (without DAC): Half-life of approximately 30 minutes. Research models show a pulse-like GH release pattern. Often studied alongside GHRP compounds.
- CJC-1295 (with DAC): Extended half-life of 6–8 days due to the DAC modification that allows albumin binding. Studies indicate a prolonged GH-releasing effect in animal models. Cjc 1295 Dac
- Ipamorelin: Half-life of approximately 2 hours. Research suggests selective GH secretion with minimal impact on cortisol or prolactin in studied models.
- GHRP-2: Half-life of approximately 30 minutes; often combined in studies with CJC-1295 to assess synergistic GH pulse amplification.
- GHRP-6: Similar half-life to GHRP-2 at roughly 15–30 minutes; studied for ghrelin receptor agonism and appetite-related signaling.
- Sermorelin: Very short half-life of approximately 10–20 minutes; frequently studied as a GHRH analogue in aging-related research.
- MK-677 (Ibutamoren): Notably long half-life of approximately 24 hours; oral bioavailability studied in metabolic and GH research contexts.
Neuropeptides and Cognitive Research Compounds
- Semax: Half-life of approximately 20–30 minutes in plasma; intranasal delivery studied for neuroprotective and BDNF-related signaling in rodent models.
- Selank: Similar short half-life of 1–3 minutes in plasma; research suggests anxiolytic-like effects may persist beyond plasma clearance due to downstream signaling.
- DSIP (Delta Sleep-Inducing Peptide): Half-life of approximately 30–60 minutes; studied in sleep architecture and stress-response research models.
- Epithalon (Epitalon): Short plasma half-life of under 60 minutes; research suggests telomerase activation effects may be cumulative over repeated administrations in animal studies.
Immune and Protective Peptides
- Thymosin Alpha-1: Half-life of approximately 2 hours; widely studied for immunomodulatory properties including T-cell and dendritic cell activity in preclinical models. Thymosin Alpha 1
- LL-37 (Cathelicidin): Short half-life of under 30 minutes; antimicrobial peptide studied for innate immune defense mechanisms.
Key Research Takeaways on Peptide Half-Life
Understanding these half-life windows is essential for structuring reproducible research protocols. A 2021 review published in Frontiers in Pharmacology highlighted that peptide modifications — particularly DAC conjugation and PEGylation — have transformed short-acting research compounds into viable candidates for sustained-release study models.
Researchers should also note that half-life figures vary considerably between in-vitro, animal, and any extrapolated contexts. The values above represent general estimates derived from published preclinical literature and should be used as a starting framework, not absolute benchmarks.
Storage and Stability Considerations
Half-life in a biological system is separate from shelf stability. Most research-grade peptides are supplied in lyophilized powder form to maximize storage life. Once reconstituted with bacteriostatic water, peptides should typically be stored at 2–8°C and used within 28–30 days, depending on the specific compound.
Maxx Laboratories supplies research-grade peptides verified by third-party HPLC purity testing, ensuring that the compounds researchers receive match the molecular integrity required for reliable results. Quality Assurance
Disclaimer
All products offered by Maxx Laboratories are intended strictly for in-vitro and laboratory research purposes only. They are not intended for human or animal consumption, and are not intended to treat, prevent, or assessed any condition or disease. All half-life data referenced in this article is derived from published preclinical and animal model research. Researchers should consult relevant scientific literature and qualified professionals before designing any research protocol.